Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.

by Thomas Celona

The Cancer Today editors share the most impactful reporting on cancer research from 2024.

by Cancer Today staff

Our favorite Cancer Today stories from 2024, as picked by the editors.

Chest radiation may not be necessary for people with intermediate-risk breast cancer.

by Thomas Celona

Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.

by Thomas Celona

Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.

by Taneia Surles

Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.

by Sandra Gordon

Cancer patients say they want to be asked about their financial needs on a regular basis.

by Pamela Appea

Ten-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.

by Cancer Research Catalyst

Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.

by Kyle Bagenstose